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ABSTRACT
Chitosan has been studied as a non-viral vector capable of efficient gene delivery due to its
favorable properties such as biodegradability, biocompatibility, and is non-toxic to mammalian
cells. Incorporating electrostatic interactions in non-viral vectors enhance the vector
permeability. This work focuses on two parts. Firstly, cationic chitosan derivatives were
synthesized using quarternary ammonium and phosphonium groups. This was achieved by
coupling carboxylic acid ligands with these quarternary groups to chitosan through an amide
bond. The carboxylic acid ligands were synthesized from 4-methylbenzoic acid and either
triethyl phosphine or triethyl amine. The ligand was then attached to chitosan through an amide
bond using hydroxybenzotriazole (HOBt) and 1-ethyl-3(3-dimethylaminopropyl)carbodiimide
(EDC). These compounds were then analyzed with 1H NMR and FT-IR analyses to determine
the extent of incorporation of triethylammonium and triethylphosphonium groups into the
chitosan backbone. Electrostatic interactions between these compounds and pDNA were studied
using agarose gel electrophoresis. At charge ratios of 4:1 N+:P- or P+:P-both triethyl
ammonium and triethyl phosphonium compounds complex with DNA. The second part of the
work focuses on previously synthesized derivatives N(1carboxybutyl-4-triethylammonium
chloride) chitosan and N(1-carboxybutyl-4-triethylphosphonium chloride) chitosan. These
compounds were also studied using dynamic light scattering, zeta potential, and circular
dichroism. These compounds were also PEGylated to aid in stability in aqueous media. The size
of DNA/polymer complexes were between 140-340 nm at varying concentrations. Zeta
potentials showed complete complexation after a weight ratio of 3:1 of polymer to DNA was
achieved. Circular dichroism measurements revealed that at weight ratios at 4:1 of polymer to
DNA that conformational changes of the DNA would occur. This work aims to investigate the
newly synthesized compounds as viable gene therapy candidates capable of enhanced affinity
towards nucleotides as well as further studying previously synthesized compounds for their
efficiency towards complexing with DNA.
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CHAPTER 1. INTRODUCTION

1.1. Chitin and Chitosan
Chitin is the second must abundant natural biopolymer behind cellulose. Chitin is a longchain polymer that consists of N-acetylglucosamine. It is found in the cell walls of fungi,
exoskeletons of crustaceans and insects, and the scales of fish.1 Chitosan is the deacetylated
form of chitin and is normally prepared by hydrolysis of chitin in aqueous sodium hydroxide.2
Figure 1 represents the formation of chitosan from chitin using chitin-deacetylase, which is an
enzyme that aids in the removal of the acetyl group.3 The degree of deacetylation can be
determined by nuclear magnetic resonance (NMR) spectroscopy. Many of the commercially
available chitosans range from 60 to 99% deacetylated. The degree of deacetylation has an
impact on the physicochemical and biological properties of chitosan including acid base and
electrostatic characteristics, biodegradability, self-aggregation, sorption properties, and the
ability to chelate metal ions.4 Distinguishing between chitin and chitosan is done by looking at
the degree of deacetylation where anything 60% or above is considered chitosan.5 Chitin and
chitosan exhibit intramolecular hydrogen bonding through its acetyl and hydroxyl groups giving
them three-dimensional α-helices structures.3,6 The helical structures of chitosan have been
studied using solid state X-ray crystallography. However, these helical structures can be
changed depending on the experimental conditions such as temperature and pH.7
Chitosan structure is closely related to that of cellulose, but it does not share the same
properties. Chitosan is insoluble in organic and neutral to basic aqueous solvents. It has been
shown that chitin with a degree of deacetylation less than 60% is soluble in dilute acid solutions.8

1

Figure 1. Chitin deacetylation using an enzyme.3

2

At pH 6, the free amino groups found on chitosan’s N-deacetylated units begin to
protonate, which increases solubility. The increased solubility allows synthetic modifications to
take place in solution. The protonation of the amino groups allows for the formation of ionic
cross-linking with multivalent anions such as phosphate.8 Chitosan also has primary and
secondary hydroxyl groups that can be synthetically modified once in solution. This ability to
alter chitosan’s amino and hydroxyl groups allow it to be useful in many applications from
soaps, cosmetics, water treatment, protein separation, gene delivery, and cancer treatments.8,9
Applications for chitosan are determined by two factors, the degree of deacetylation and
its molecular weight (MW). The degree of deacetylation and MW allow for specific
physicochemical interactions making chitosan a suitable non-viral vector.8 The higher the
degree of deacetylation, the more amino groups are present for modification and protonation.
The stability of chitin’s α-helix is disrupted by a higher degree of deacetylation and an increase
in protonation of free amino groups. This allows for greater solvation and cationic interactions
with chitin. When the degree of deacetylation is lower than 40%, intramolecular hydrogen
bonding and hydrophobic methyl groups make chitin insoluble in water.8,10 When the degree of
deacetylation is higher, chitin is less sterically hindered and has less intramolecular interactions
making it soluble in aqueous solvents with lower pH.10–12
Chitosan microbial degradation is a factor of the degree of deacetylation and distribution
of N-acetylated glucosamine units throughout the polymer chain. It was found that once the
degree of deacetylation reaches higher than 70% that chitosan’s degradation process rapidly
declines.13 Another study showed that chitosan with homogenous distribution of N-acetylated
glucosamine units was less susceptible to degradation within lysosomal space.14 With the
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control of these two parameters, chitosan’s ability to degrade within biological systems can be
affected.
MW can significantly affect chitosan’s function in a variety of applications that include
burn healing, coagulation of pollutants, lowering blood cholesterol levels, enhancing drug
dissolution, control of viscosity, and improving crop yields.8,15 Different MW have been shown
to influence the growth of E. coli. cells. Higher MW prevented E. coli. growth, while lowering
the MW promoted it. Sodium nitrite can be used to depolymerize chitosan controllably, allowing
for a wide range of MW chitosan.16 The MW can also determine the strength of interaction
between DNA and chitosan. In acidic solution, electrostatic attraction between protonated
chitosan and DNA occurs. Higher MW chitosan can wrap around short (24 base pair) doublestranded DNA and create a stronger interaction through entanglement.17 Because low MW
chitosan does not exhibit this entanglement effect, it is less effective at condensing short doublestranded DNA.18 The electrostatic attraction between DNA and chitosan is generated by the
protonation of the free amino groups on chitosan. When the pH is increased, the interaction is
lost as a result of the deprotonating of the amino groups.
Chitosan can be chemically modified to bear pH-independent cationic groups that can
provide sustained interactions with short double-stranded DNA through a broad pH range.16 The
degree of complexation of short double-stranded DNA with chitosan can be controlled by
changing the positive to negative charge ratio (+/-).This ratio is determined by the amount of
negatively charged phosphate groups on DNA and comparing that to the positively charged
ammonium or phospohonium groups on chitosan. Many advantages are associated with using
cationic macromolecules to bind DNA including ease of functionalization, higher stability
relative to lipoplexes, and lower toxicity.19 Chitosan derivatives have also shown to bind to
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specific moiety that viral vectors cannot.20 Synthesizing chitosan derivatives with cationic
functional groups that are not dependent on pH can provide a way for chitosan to become a
viable non-viral vector suitable for gene therapy.

1.2. Chitosan Modification
Modifications have been made to chitosan to improve solubility in neutral conditions.
Chitosan derivatives with various functional groups have been prepared for various applications
in the biomedical field as seen in Figure 2.21 Chitosan’s amino and primary hydroxyl groups
allow for chemical modification that can lead to an increase in solubility and affinity for
nucleotides. Hydroxyl groups can be modified to carboxymethyl groups in order to increase
solubility. Chitosan itself is non-toxic to mammalian cells, but the addition of cationic groups
can increase toxicity.22
One such modification requires coupling carboxylic acids to amino groups to form a
more stabilized amide. This coupling requires a preliminary activation step to create a stable
intermediate that is more reactive toward amino groups.23 In 1995, experiments were conducted
to observe the effects on coupling efficiency using altered carbodiimides.24 N,N’dicyclohexylcarbodiimide (DCC) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)
were reacted with various nucleophiles to observe the reaction mechanism. For both EDC and
DCC, the rate-limiting step was the formation of O-acylisourea, where the fully-protonated
carbodiimide and the carboxylate ligand react to form a reactive intermediate. The Oacylisourea complex is very reactive and short-lived in solution.23 At a pH lower than six, the
intermediate hydrolizes, thus reforming the carboxylic acid ligand and a deactivated EDC-urea.
At pH’s between 6-8, the intermediate remains in solution long enough to encounter amino
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Figure 2. Examples of chitosan derivatives for biomedical applications.21

6

groups and undergo successful coupling. Using EDC and DCC has been shown to be successful
when coupling carboxylic acids to amino groups, but other additives have been
studied to improve coupling efficiency. Hydroxybenzotriazole (HOBt) has been used in
carbodiimide reaction schemes to stabilize the O-acylisourea intermediate. HOBt attacks the
activated EDC-carboxy intermediate and forms a more stable intermediate that can remain in
solution for an extended period of time, increasing the overall efficiency of the EDC/HOBt
coupling scheme.23 The primary amines on chitosan can be linked with functionalized
carboxylic acids using EDC and HOBt.22,25 Water-soluble EDC can be used to make these
modifications at room temperature under open air conditions. Cationic modification to chitosan
is done by first using EDC followed by HOBt. These modifications allow chitosan to interact
with short double-stranded DNA.24,26 Figure 3 illustrates the mechanism for these carboxylic
acid attachments to chitosan.27

1.3. PEGylation
PEGylation is defined as the coupling of polyethylene glycol (PEG) to other materials.
Chitosan’s ability to interact with DNA has been improved through several modifications
including PEGylation.26 The Food and Drug Administration (FDA) has approved of the use of
PEG in biomedical and biotechnical fields. It has been used in many applications from
cosmetics to drug delivery systems.28 PEGs are classified as polyethers, linear and branched,
that have molecular weights ranging from 300 to 40,000 g/mol.28 PEGs with lower molecular
weights have lower melting points and are liquids at room temperature. High molecular weight
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Figure 3. Reaction Mechanism of EDC and HOBt coupling carboxylic acid ligand to chitosan.27

PEGs have higher melting points and are crystalline at room temperature. These behaviors can
be explained by looking at chain length. The high molecular weight PEGs have longer chains.
These longer chains become entangled and create more intermolecular forces that increase the
melting point.29 The most commonly used PEG is methoxy polyethylene glycol (mPEG). This
derivative contains a hydroxyl group at one end and a methoxy group at the other.28 PEGs are
soluble in many aqueous and organic solvents making them a prime candidate for work with
organic transformations. Adding PEGs to medications and gene delivery vectors increases
solubility which then increases the medications efficiency.28 PEGylating chitosan produces
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conjugates with reduced toxicity and increased stability in aqueous media.28 Introducing PEG
into pharmaceutical applications, such as gene therapy, is often encouraged.30 PEG-grafted
chitosan has been prepared to lower toxicity of certain cationic chitosan derivatives and increase
water solubility.28 These PEG-grafted non-viral vectors have been shown to stabilize
complexation of short double-stranded DNA through shielding of the positive charges present on
modified vectors. PEG-grafted vectors have displayed higher solubility and complexation with
short double-stranded DNA when compared to their non-PEGylated counterparts.30

1.4. Gene Therapy
Chitin and chitosan have been studied for their application in gene therapy since the early
1990’s when their structures were identified using infrared spectroscopy (IR). Chitosan
compounds are among the non-viral vectors heavily researched for gene delivery due to their low
toxicity in mammalian cells and naturally high abundance.8 Therapeutic fields have been
researching gene therapy for over twenty years.25 Introduction of new genetic material to
diseased genes has been shown to restore functionality of damaged genes.31 This same method
has also been used to investigate inherited single gene disorders.31 Gene delivery vectors, or
vehicles, are needed to transfer new genetic material into or near the desired therapeutic sites.
The transfer of this material can occur through techniques such as ex vivo, in vivo, or in situ.8
Viral and non-viral vectors are utilized with many gene therapy approaches.3 Viral gene
delivery uses viruses to infect cells with the new genetic material. These viruses can be
modified to stop their reproductive cycle by removing genetic sequences needed for
reproduction. However, they require sequencing of the viruses for binding and gene delivery to
be useful.32 Commonly used viral vectors include retrovirus,8,33,34 adenovirus,8,9 adeno-
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associated viruses,35 herpes virus,36 and vaccinia virus.8,37 Each of the listed viral vectors has
been incorporated into its own unique application. A few of these viruses can produce sustained
gene expression but only in cells that divide. Others are just as effective against non-dividing
cells without integrating into their host cell chromosome.38 Viral DNA can integrate into the
genomes of the cell causing mutations in the cell that lead to safety concerns.32 The safety
concerns of viral gene delivery began to grow after the accidental death of a patient using gene
therapy for immune deficiency.22 Due to the fear of using viral vectors, increased investigations
into using non-viral vectors have been pursued.
Non-viral vectors can deliver large fragments of genetic material to mammalian cells
comparable to that of viral vectors.22 These vectors have been successful, but are less effective
than viral vectors in transfecting mammalian cells.39 There have been many investigations for
improving these non-viral vectors for gene delivery. Addition of cationic polymers, mainly
dendrimers and short chain oligomers, have been found to meet the pharmaceutical standards for
human use.40 Dendrimers have been shown to form complexes with plasmid DNA (pDNA) and
are regarded as one of the most effective non-viral vectors.41 However, there have been recent
studies that have raised concern over the use of dendrimers in biological systems due to their
toxicity.42,43 Decreasing the molecular weight and lowering the degree of branching of these
dendrimers have been shown to slightly lower the toxicity in biological systems.44–46 Cationic
polymers that can be formed in long-chain fashion or polycationic-spherical balls have been
shown to have increased interaction with pDNA.44–47 Short-chain polymers have been shown to
have weaker interactions and lower overall solubility.42,43 Linear polysaccharides, such as
chitosan, have been proposed as biocompatible gene delivery vectors that can be tailored for
electrostatic interactions. Studies have shown that chitosan exhibits low cytotoxicity within
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mammalian cells and displays viability in gene therapy.44–48 Current research shows that high
molecular weight chitosan derivatives have been shown to exhibit the highest complexation and
stability with pDNA.31,49–52

1.5. Particle Sizing and Zeta Potential
When the chitosan compound complexes with DNA, the complex must meet a certain
size requirement before uptake in the cells will happen. Particles with diameters less than 0.5
µm are internalized through phagocytosis while particles with diameters less than 0.2 µm are
internalized through pinocytosis.53 In a study done by Kim et al., most of the modified
chitosan/DNA complex nanoparticles were below 400 nm in diameter.54 These diameters are
normally determined by dynamic light scattering (DLS). This technique utilizes light rays and
how they scatter when they hit small particles. When the light scatters, its intensity fluctuates
due to the particles’ Brownian motion. The scattered light also interferes, either constructively
or destructively, with other particles in the solution. Depending on how the scattered light
interacts with the particles, size can be determined by the Stokes-Einstein equation. This
equation provides the hydrodynamic radius of the particles which is used in most studies.55
Another useful tool for determining complexation with DNA is zeta potential. The zeta
potential is the electrical potential at the slipping plane. This plane is the interface which
separates mobile fluid from fluid that remains attached to the surface. Zeta potential is caused by
the net electrical charge contained within the region bounded by the slipping plane. For this
reason, it is used for quantification of the magnitude of the charge of the fluid.56 It is determined
through electrophoresis, meaning that an electric field is applied to the solution. Particles with a
zeta potential will migrate to the electrode of opposite charge with a velocity proportional to the
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zeta potential. A laser is used to determine the velocity. As the particles move to the electrode,
they shift the frequency of the laser. This shift is then converted to the particle mobility which is
then converted to zeta potential by inputting the viscosity and dielectric permittivity and
applying the Smoluchowski theories.57 When the zeta potential is negative, the net charge of the
particles is negative. When it is positive, the overall charge of the particles is positive. Since
DNA has phosphate groups on the backbone, particles in the solution containing only DNA will
be negatively charged. Chitosan compounds used for vectors are positively charged, so the
particles in a solution of modified chitosan compounds will have a positive zeta potential.
Complexation can be determined by measuring naked DNA and adding increasing amounts of
chitosan compounds. As the chitosan complexes with DNA, the zeta potential will become less
negative. Once complete complexation has occurred, the zeta potential will be zero. Adding
more chitosan compounds past this point will result in a solution with positive charge. In this
work, the zeta potential was used alongside gel electrophoresis to determine complexation.

1.6. Previous Work
Previous studies have shown that adding ammonium, phosphonium, and mPEG groups to
chitosan increases solubility and electrostatic interactions with DNA. Multiple groups have
added phosphonium groups to chitosan for non-viral gene vectors using HOBt, and EDC. They
found that the derivatives were soluble in aqueous solutions and had very low toxicity.31,58,59
Using this information, we decided that adding these groups onto chitosan would be beneficial.
In previous studies, Wyatt synthesized two different compounds containing the ammonium and
phosphonium groups, N-(1-carboxybutyl-4-triethylammonium chloride) chitosan (TEAB-CS)
and N-(1-carboxybutyl-4-triethylphosphonium chloride) chitosan (TEPB-CS). The procedure
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for synthesizing these compounds used hydroxybenzotriazole (HOBt) and 1-ethyl-3-(3dimethylaminopropyl) carbodiimide (EDC) as the coupling agents for the coupling of the amines
or phosphines to carboxylic acids. Once the carboxylic acid and amine/phosphine are coupled,
the carboxylic acid can react with an amine on chitosan to form an amide bond. The resulting
compounds could then be analyzed using proton nuclear magnetic resonance (1H NMR) to
determine the percent substitution of the amine/phosphine group on chitosan.27 These
compounds showed increased solubility as well as electrostatic interaction with DNA. However,
size of the complexes were never studied, an important factor in the process of cellular uptake.
Other groups such as Kean et al. have synthesized trimethylated chitosan derivatives for
use in non-viral gene delivery. This process involved dissolving chitosan in 1-methyl-2pyrrolidinone (NMP) with sodium iodide. Sodium hydroxide was then added to maintain an
alkaline environment. Methyl iodide was added to the solution in order for methylation to occur
through nucleophilic substitution. The derivatives cytotoxicity’s were then studied to determine
viability as a gene delivery vector. It was found that these compounds are less toxic than the
gold standard of linear polethylenimine. These compounds also interacted with pDNA at weight
ratios of 10:1 (w/w derivative:pDNA) when studied using agarose gel electrophoresis. 60 These
studies serve as the basis of the work presented in this thesis.

1.7. Purpose of this Work
In this research, two goals were established. Firstly, synthesis of ammonium and
phosphonium chitosan derivatives different than those prepared by Quinton Wyatt. Wyatt
synthesized chitosan derivatives that had short alkyl chains attached to a triethylammonium or
triethylphosphonium group. The compounds that were synthesized in this work have a benzene
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ring between the ammonium/phosphonium group and the amide bond on chitosan. These
compounds aim to increase the hydrophobicity while still providing the same amount of
electrostatic interaction with DNA. Using previous established methods for synthesizing
chitosan derivatives, two novel compounds were synthesized, N-(1-carboxymethyl-4triethylammonium chloride) methylbenzoic acid (TEABA-CS) and N-(1-carboxymethyl-4triethylphosphonium chloride) methylbenzoic acid (TEPBA-CS). Triethyl
ammonium/phosphonium benzoic acid ligands were attached to 95% DA chitosan using HOBt
and EDC. To determine if the degree of substitution could be manipulated, differing amounts of
ligand were attached to the same amount of chitosan in multiple reactions. These cationic
chitosan derivatives were then analyzed using 1H NMR and Fourier Transform-Infrared
Spectroscopy (FT-IR) to prove that the ligand had attached to chitosan. Agarose gel
electrophoresis was then used to determine concentrations at which complexation with DNA
occurs. The second goal of this work was to complete characterization of Wyatt’s compounds
(TEAB-CS and TEPB-CS). The compounds were first PEGylated and studied using gel
electrophoresis. Circular Dichroism (CD) was used to study the effect of these compounds on
DNA conformation. Size, zeta potential, and solubility studies were conducted to finish the
work on these compounds. Figure 4 shows the chitosan derivatives worked on for this project.
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TEAB-CS

TEAB-mPEG-g-CS

TEPB-mPEG-g-CS

TEPB-CS

TEPBA-CS

TEABA-CS

Figure 4. Chitosan derivatives prepared and used in this study.
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CHAPTER 2. EXPERIMENTAL METHODS

2.1 Materials and Instrumentation
2.1.1 Materials. 95% deacetylated chitosan (medical grade) was purchased from
Bonding Chemical Co.. 4-(bromomethyl) benzoic acid, methyl-4-(bromomethyl) benzoate,
triethyl amine, triethyl phosphine, calf thymus DNA, and ethyl alcohol were purchased from
Sigma Aldrich. 1-Ethyl-3-(3dimethylaminopropyl) carbodiimide (EDC) was purchased from
Chem Empex. DMSO, DMSO-d6, D2O, and hydroxybenzotriazole (HOBt) were purchased from
Alfa Aesar. Dr. Kyoungtae Kim provided the pDNA used for the gel electrophoresis.
2.1.2. Nuclear Magnetic Resonance (NMR). The carboxylic acid ligands and chitosan
derivatives were studied using 1H NMR spectroscopy on a Varian 400 MHz NMR spectrometer.
Bruker TopSpin processor software was used for data analysis of the spectra. Studies were
conducted at 25℃ in D2O or DMSO. D2O was used for the chitosan derivatives and DMSO was
used for the carboxylic acid ligands. Samples were prepared by weighing out 2 mg of compound
and placing in 700 µL of solvent. These samples were then placed in a Branson 2510 ultrasonic
bath for 15 minutes to completely dissolve. The samples were analyzed using 5 second
acquisition time, 5 second relaxation, 90º pulse angle, and auto gain control. The results for
these studies are found in Appendix A.
2.1.3. Fourier-Transform Infrared Spectroscopy (FT-IR). The synthesized
compounds were studied using Fourier-transform infrared spectroscopy to confirm the coupling
of the carboxylic acid ligands to N-glucosamine units. A Bruker Vertex 70 FT-IR with Bruker
OPUS 7.5. software was used for these analyses. Experiments were conducted using KBr
pellets. Briefly, 1 mg of sample was added to 100 mg of KBr. All runs were carried out using a
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wavenumber range of 4000-400 cm-1, 2 cm-1 resolution, 100 scans, and automatic atmospheric
correction. The results for these studies are found in Appendix B.
2.1.4. Agarose Gel Electrophoresis. Agarose gel electrophoresis was conducted in pH
7.4 tris acetate EDTG (TAE) buffer using 2% agarose gels, 2 µL of pDNA (187 µg/mL), 2 µL of
loading dye, and varying amounts of chitosan derivatives to give N+/P- or P+/P- ratios from 8 to
½ (where P- is the phosphate on DNA and N+ or P+ is the ammonium or phosphonium group on
chitosan). Visualization was done using an Azure biosystems gel reader.
2.1.5. Circular Dichroism (CD). CD analysis was conducted using a Jasco J-815
spectrometer coupled with a PFD-425s single positions peltier. Samples were loaded into a
cuvette with a path length of 1 mm and volume of 400 µL. Distilled deionized water was used
for background measurements. After background measurements, calf thymus DNA was added to
the cuvette to a final concentration of 100 µg/mL and scanned. After this scan, increasing
amounts of chitosan derivatives were added to the DNA solution to give weight ratios from 1 to
16. Each sample was scanned 3 times at a speed of 50 nm/min at room temperature. Data points
were collected every 0.025 nm. The results were then exported to Microsoft Excel and
processed. Results from these studies are found in the Results and Discussion Section.
2.1.6. Dynamic Light Scattering (DLS) Size Determination. Particle size for the
polymer/DNA complexes at various weight ratios were determined using Brookhaven
NanoBrook Omni particle analyzer with BIC operating software. Samples were prepared in both
water and PBS buffer (7.4) to a final volume of 3 mL. Calf DNA was added to a final
concentration of 100 ug/mL. Chitosan compounds (1mg/mL) were then added in weight ratios
from 1 to 10 then allowed to sit for 15 minutes. Measurements were taken at a 90º
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backscattering angle for 90 seconds and run in triplicate. Results are discussed in the Results
and Discussion section.
2.1.7. Zeta Potential. Zeta potential studies were done with polymer/DNA complexes
similar to those for DLS size measurements. The Brookhaven NanoBrook Omni particle
analyzer was used with BIC operating software. An electrode provided by Dr. Adam Wanekaya
was used to deliver the voltage in the sample. Samples were prepared in water to a final volume
of 1.5 mL. Calf DNA was added to a final concentration of 15 µg/mL. Chitosan derivatives
(1mg/mL) were then added in weight ratios from 1:8. Measurements were taken using 3 cycles
of electric charge passing through the solution. After 3 cycles, the zeta potential was averaged
by the instrument. Each sample was run in triplicate and results are discussed in the Results and
Discussion section.
2.1.8. Solubility Studies. Solubility studies were conducted using a Varian Cary 50
UV-Vis spectrophotometer. 1.00 mg of chitosan and its derivatives were dissolved in 5.00 mL
of 1% aqueous acetic acid. The pH was gradually increased using 0.1 M NaOH until a pH of 10
was obtained. %T data was collected at various pH ranges from 1.75 to 10. A Fisher Science 810
series pH meter was used to determine pH. The wavelength of 600 nm was used in %T
evaluation. The compounds do not absorb at this wavelength, but when a phase separation
occurs, such as that when the compounds become insoluble, then the light scattering is
significant and used to determine solubility points.
2.2. Synthesis of Methyl-4-(triethylammonium bromide) Methyl Benzoic Acid
2.000 g of methyl-4-(bromomethyl) benzoate was placed in 2.5 mL of triethyl amine.
The contents were placed in 50 mL of methanol and refluxed overnight. Methanol was
evaporated using a Heidolph model 036000820 rotary evaporator. An oily substance was formed

18

and completely dried using a vacuum oven. After drying, the compound was hydrolyzed using
3M HCl and refluxed overnight. The mixture was allowed to cool and solvent was evaporated
using a Heidolph model 036000820 rotary evaporator. This resulted in an oily substance that
was washed and precipitated with cold acetone. After the washing with 10 mL acetone, the
precipitate was collected and dried in a vacuum oven for 2 days. This yielded 2.881 g of product
(75% yield). The final product was examined using 1H NMR spectroscopy for full reaction. The
reaction scheme for the synthesis of ethyl-4-(triethylammonium bromide) methyl benzoic acid
(TEABA) is detailed in Figure 5.

Figure 5. Reaction scheme for synthesis of TEABA ligands.

2.3. Synthesis of Methyl-4-(triethlyphosphonium bromide) Methyl Benzoic Acid
4.000 g of 4-Bromomethyl benzoic acid was placed in 150 mL of toluene. Under an
atmosphere of nitrogen, 2.8 mL of triethyl phosphine was added to the mixture and refluxed for
24 hours. A white precipitate formed and was filtered out of solution then washed with diethyl
ether 3 times. The washed precipitate was dried in a vacuum oven overnight. The final product
was methyl-4-(triethlyphosphonium bromide) methyl benzoic acid (TEPBA) and yielded 5.624g
(90% yield). Figure 6 shows the reaction scheme for the phosphonium carboxylic acid ligand.
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Figure 6. Reaction scheme for synthesis of TEPBA ligands.
2.4. Synthesis of Ammonium/Phosphonium Chitosan Derivatives
Mole ratios of chitosan to carboxylic acid derivatives were calculated to help determine if
the degree of substitution of ligand could be controlled. Ratios used were from 1:1
(acid:chitosan) to 5:1. The corresponding amount of acid ligand was then dissolved in 2 mL of
DMSO. In another solution, 0.250 g of 95% deacetylated chitosan were suspended in 20 mL of
water. 0.750 g of HOBt were dissolved in 10 mL of DMSO and added dropwise to the chitosan
solution. This was allowed to stir until completely soluble. Once soluble, the acid ligand
solution could be added along with 0.850 g of EDC. This mixture was stirred for 24 hours.
After stirring, the solution was dialyzed using a molecular weight cutoff 12,000 KDa cellulose
dialysis tube suspended in deionized water. The water was dumped and replaced every 24 hours
and the tube was in water for 3 days. The solution within the tube was then frozen using liquid
nitrogen and lyophilized for 3 days. The freeze dried product was analyzed using 1H NMR
spectroscopy to determine reaction completion and degree of substitution. The final products
were the ammonium/phosphonium carboxylic acid substituted chitosan derivatives. Varying
reactions were conducted with yields from 26-88 %. Figure 7 shows the scheme for this
reaction.
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Figure 7. Reaction scheme for attaching carboxylic acid ligands to chitosan. A+ represents
either N+ or P+.
2.5. PEGylation of TEAB-CS and TEPB-CS
TEAB-CS was PEGylated by dissolving 0.60 g of the compound in 22.5 mL of 2:1 (v:v)
H2O/DMSO mixture. 0.13 g of HOBt, 0.18 g of EDC, and 1.00 g of mPEG (5000) acetic acid
were added to the solution and stirred overnight. Another portion of 0.13 g of EDC were added
and stirred for an additional 4 hours. The mixture was dialyzed for two days and then freezedried. The product was soaked in methylene chloride and filtered and washed 3 times, each time
with 5 mL of fresh methylene chloride and then dried to obtain 0.43 g of the product.
TEPB-CS PEGylation was carried out the same way as TEAB-CS-g-mPEG. 0.40 g
TEPB-CS, 0.13 g HOBt, 1.03 g mPEG (5000) acetic acid, and 0.18 g EDC yielded 0.60 g of
product. The DS for grafting mPEG into chitosan was determined by 1H NMR for both
compounds and is discussed in the Results and Discussion section.
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CHAPTER 3. RESULTS AND DISCUSSIONS

3.1 1H NMR Analysis
3.1.1. Ammonium and Phosphonium Carboxylic Acid Ligands. The carboxylic acid
ligands containing ammonium and phosphonium groups were analyzed with 1H NMR
spectroscopy. These compounds were 4-methyltriethylammonium benzoic acid and 4methyltriethlyphosphonium benzoic acid. The results of each study can be viewed in Appendix
A. Integration lines and their values are indicated in red. Peak signals are labeled with numbers
above the spectra corresponding to the chemical shift of that peak. After drying of the samples,
2 mg of each were dissolved in 700 µL of DMSO or D2O. Chemical shift values for both
ammonium and phosphonium carboxylic acid ligands are shown in Table 1.

Table 1. 1H NMR assignments for synthesized carboxylic acid ligands
Ligand Name

Abbreviation

1

H NMR ppm

methyl-4-(triethlyammonium
bromide) methyl benzoic acid

TEABA

7.95, 7.50 (4H, C6H6CH2N+(CH2CH3)3), 4.34
(2H, -CH2N+(CH2CH3)3), 3.11
(6H, -N+(CH2CH3)3), 1.25 (9H, N+(CH2CH3)3)

methyl-4-(triethlyphosphonium
bromide) methyl benzoic acid

TEPBA

7.89, 7.31 (4H, C6H6CH2P+(CH2CH3)3), 3.64
(2H, -CH2P+(CH2CH3)3), 2.05
(6H, -P+(CH2CH3)3), 1.05 (9H, P+(CH2CH3)3)

Both spectra show two peaks from 7.30 ppm and 7.95 ppm (2H) which are assigned to
the protons on the benzene ring. TEPBA shows peaks with heavy splitting at 1.05 ppm (9H)
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corresponding to the end methyl groups on the phosphonium group. The integration for the
benzene hydrogens were 1.00 and 1.09, indicating that integration was done properly. This
would mean that each hydrogen has an integration value of 0.53 after averaging the two
integrals. The integrals from the heavily split peak at 1.05 ppm has an integral value of 4.85.
This means that each hydrogen was integrated with a value of 0.54. These numbers match up
relatively well and show that successful substitution of bromide for triethylphosphine had
occurred. In TEABA spectrum, the benzene peaks have integrations of 1.00 and 1.09 giving a
single hydrogen integration value of 0.53. The peak from the end methyl groups at 1.25 ppm
have an integration of 5.06 which results in each hydrogen having an integral value of 0.56.
These numbers are consistent and again show complete substitution of bromine with
triethylamine.
An interesting difference in the two spectra show that the peaks assigned to the same
hydrogens (X+(CH2CH3)3) have shifted quite substantially. In TEPBA, the peak is labeled at
2.05 ppm while for TEABA that same peak is at 3.11 ppm. This can be attributed to the
shielding effect caused by the difference of phosphorus and nitrogen. Since nitrogen is more
electronegative, the deshielding from it is greater and causes a large shift downfield. This can be
seen in the spectra in Figure 8.
3.1.2. Ammonium and Phosphonium Chitosan Derivatives. Chitosan derivative
prepared from the quarternary carboxylic acid ligands were also studied using 1H NMR. Again,
these spectra can be found in Appendix A. Each sample was prepared using 2 mg of the polymer
and 700 µL of D2O. Then it was placed in the ultrasonic bath to completely dissolve. Red lines
indicate integral lines wither their values displayed below the peak. Peak signals are above their
respective peak.
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TEPBA

TEABA

Figure 8. 1H NMR spectra of carboxylic acid ligands in DMSO.
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Both sets of spectra show benzene ring peaks between 7.40 and 7.85 ppm (2H). The
peaks between 4.00 and 3.20 ppm correspond to the protons found on the glucosamine units of
chitosan. For the TEABA-CS, the peak at 3.16 ppm (2H) represents the methylene peak between
benzene and the ammonium group (-CH2N+(CH2CH3)3). The peak at 2.70 ppm (6H) represents
the first carbon on the ethyl chain after the N+ (-N+(CH2CH3)3). Peaks for the end of the ethyl
chain are at 1.30 ppm (9H). For TEPBA-CS, the methyl peak shows up at 2.72 ppm (2H). The
peak at 2.19 ppm (6H) correspond to the first carbon in the ethyl chain after phosphonium (P+(CH2CH3)3). The final peak at 1.19 ppm (9H) correspond to the final hydrogens on the ethyl
chain. Figure 9 displays the spectra for both chitosan derivatives.
The degree of substitution (DS) could also be determined using the 1H NMR spectra for
each compound. Since all of the compounds contained peaks for the terminal hydrogens on the
quarternary group (-X+(CH2CH3)3), the integral value for those peaks can be divided by 9. This
would then give the integral value for 1 hydrogen on that group. The same can be done with the
chitosan peak from 4.00-3.20 ppm. In this case, there are 6 hydrogens that are present in one
glucosamine unit. By dividing the total integration value of those peaks by 6, a single hydrogen
value can be obtained. Taking the value for the terminal hydrogen integration value and dividing
it by the glucosamine units integration value and multiplying by 100 gives the degree of
substitution. In other words, this number explains how many glucosamine units have the
carboxylic acid ligands attached to them. Figure 10 features the equation used to find the DS of
all the chitosan derivatives that were studied. These values were then compared to determine if
the DS could be manipulated to by changing the amount of acid ligand that was used in the
reaction. Table 2 contains all the DS values for each compound synthesized in this work.
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TEPBA-CS

TEABA-CS

Figure 9. 1H NMR spectra of carboxylic acid substituted chitosan derivatives in D2O.
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𝐷𝑆 =

𝐼𝑠 ÷ 𝐻𝑠
∑ 𝐼𝑐ℎ𝑖𝑡𝑜𝑠𝑎𝑛(4.0−3.3 𝑝𝑝𝑚) ÷ 6

Figure 10. Equation used for calculating the degree of substitution where Is is the integrated
signal value for the carboxylic acid ligand, Hs is the number of protons associated to the ligand,
and Ichitosan is the integrated signal value for chitosan protons.

Table 2. Calculated degree of substitution (DS) for all chitosan derivatives.
Compound

Degree of Substitution
(DS)
16.8%

Yield (mg)

% Recovery

TEPBA-CS-4

Molar Ratio
(acid:chitosan)
1:1

200

26.7

TEPBA-CS-7

1:1

28.1%

362

32.9

TEPBA-CS-5

2:1

16.0%

130

52.0

TEPBA-CS-6

2:1

28.7%

237

94.8

TEPBA-CS-3

2:1

21.9%

394

78.8

TEPBA-CS-8

2:1

23.8%

277

50.3

TEPBA-CS-10

2:1

22.6%

626

79.2

TEPBA-CS-11

2:1

34.2%

38

2.8

TEABA-CS-1

2:1

33.1%

221

88.4

TEABA-CS-2

1:1

25.8%

194

22.4

TEABA-CS-4

1:1

14.8%

459

62.4

TEABA-CS-5

3:1

25.0%

185

25.8

TEABA-CS-6

3:1

17.6%

586

49.5

TEABA-CS-7

3:1

21.6%

675

69.7

TEABA-CS-8

5:1

28.2%

220

37.8
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As can be seen from Table 2, it seems that the degree of substitution was not dependent
on the amount of acid added to the reaction mixture. In many cases, it was difficult to get a
consistent number with identical runs. This means that there must be other factors involved in
the DS that don’t include the acid ligand. Unfortunately, the DS could not be controlled through
changing the ratio of acid ligand to chitosan to any reasonable degree.
3.1.3. PEGylated Chitosan Derivatives. TEAB-CS and TEPB-CS were PEGylated as
discussed in the Experimental Methods section and studied using 1H NMR to determine addition
of mPEG to chitosan. Both spectra show the addition of mPEG into chitosan as 3.54 ppm and
3.37 ppm for TEAB-CS-mPEG and TEPB-CS-mPEG respectively. The DS for the mPEG
attached to chitosan was also calculated. This was done by calculating the integral value for one
methyl proton at around 1.1 ppm for both compounds. The integration value for the six chitosan
protons on the substituted derivative was calculated using percent substitutions calculated by
Wyatt. The integral values for the six chitosan protons and the corresponding integration values
for the 12 protons on the TEAB group were subtracted from the total integration value from
2.60-4.00 ppm to obtain the integration value for mPEG. The percent substitution for mPEG was
then calculated by comparing the integration value for one mPEG proton with that of chitosan.
For TEPB-CS-g-mPEG the DS of mPEG was 2.6% and TEAB-CS-g-mPEG was 3.1%. Figure
11 shows the spectra of these two PEGylated derivatives.
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TEAB-CS-g-mPEG

TEPB-CS-g-mPEG

Figure 11. 1H NMR spectra of PEGylated TEAB-CS and TEPB-CS in D2O
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3.2. FT-IR Analysis
FT-IR analysis was conducted on two different chitosan derivatives to determine changes
in the spectra after attachment of the carboxylic acid ligand. 95% deacetlyated chitosan was also
analyzed as a control. Peaks at wavenumbers near 1640 cm-1 and 1550 cm-1 were observed for
both ammonium and phosphonium derivatives, indicating that amide bond formation had
occurred between chitosan and the ligands. C-N+ stretching was observed for the ammonium
chitosan derivative near wavenumber 1450 cm-1 consistent with findings from Tan et al.31 C-P+
stretching for the phosphonium derivative was observed near wavenumber 1451 cm-1 consistent
with those found by Qian et al.58 Peaks observed from 3440-3420 cm-1 are assigned to the
hydroxyl and amino groups found on the glucosamine units of chitosan. C-H stretching was
observed for chitosan and the two derivatives around wavenumber 2920 cm-1, although the
ammonium derivative seems to have a less prominent peak at this position. Peaks at
wavenumbers near 1650 cm-1 are associated to the C=O stretching vibrations from the amide
bonds. N-H bending vibrations from the amides are at 1550 cm-1. C-O stretching from carbons
on the chitosan ring were observed at wavenumbers 1099-1074 cm-1. Figure 12 shows all the
spectra overlayed to help compare chitosan to the derivatives. Individual spectra are found in
Appendix B.
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1451
2920
1099-1074
1450
3440-3420

1640

Figure 12. FT-IR spectra of chitosan, TEABA-CS, and TEPBA-CS.

3.3. Agarose Gel Electrophoresis
Agarose gel electrophoresis was conducted to determine concentrations at which the
chitosan derivatives would completely complex with pDNA. The concentration of pDNA was
187 µg/mL with 3,792 base pairs provided by Dr. Kyoungtae Kim. Concentrations of the
polymer solutions were then calculated to give charge ratios ranging from 8x-1/2x for TEABACS and 16x-1/4x for TEPBA-CS. Charge ratios are expressed as N+:P- or P+:P- where the

31

positive charge is from the chitosan derivatives and the negative charge is the phosphates on
pDNA. For charge ratios above 4x, complete complexation can be observed for all chitosan
derivatives synthesized in this study. This can be seen in Figure 13 by the lanes where the
pDNA has not migrated out of the well. In all other wells, the pDNA moves down the gel
signifying that pDNA is uncomplexed. As can be seen in Figure 13, both ammonium and
phosphonium derivatives have the same interaction with pDNA at the various charge ratios. It
should be noted that the derivatives used for this study were the ones with the highest DS,
TEPBA-CS-11 and TEABA-CS-1. Since both compounds had a DS between 33% and 34% they
compare quite well.

TEABA-CS-1

1 2 3

4 5

TEPBA-CS-11

6

1 2 3 4 5 6 7 8

Figure 13. Agarose gel electrophoresis results for TEABA-CS-1 and TEPBA-CS-11. TEABACS-1 charge ratios are as follows: Lane 1 (8:1), Lane 2 (4:1), Lane 3 (2:1), Lane 4 (1:1), Lane 5
(1/2:1), Lane 6 (naked pDNA). TEPBA-CS-11 charge ratios are as follows: Lane 1 (16:1), Lane
2 (8:1), Lane 3 (4:1), Lane 4 (2:1), Lane 5 (1:1), Lane 6 (1/2:1), Lane 7 (1/4:1), Lane 8 (naked
pDNA). Weight ratios were also determined. TEABA-CS-1 weight ratios are as follows: Lane 1
(2.80:1), Lane 2 (1.35:1), Lane 3 (0.67:1), Lane 4 (0.33:1), Lane 5 (0.17:1), Lane 6 (naked
pDNA). TEPBA-CS-11 weight ratios are as follows: Lane 1 (4.60:1), Lane 2 (2.80:1), Lane 3
(1.35:1), Lane 4 (0.67:1), Lane 5 (0.33:1), Lane 6 (0.17:1), Lane 7 (0.09:1), Lane 8 (naked
pDNA).
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Gel electrophoresis was also run on TEAB-CS and TEPB-CS. In those cases, the compounds
show complete interaction with DNA at charge ratios at 4x or higher. This translates to a weight
ratio of 1.35 polymer to DNA. Figure 14 shows the results in terms of charge ratio and weight
ratios. It is interesting to note that both PEGylated and non-PEGylated compounds show the
same results. PEGylation would seem to not have any effect on the interaction of chitosan with
pDNA with these derivatives.

Figure 14. pDNA-binding ability of TEAB-CS (A), TEAB-CS-g-mPEG (B), TEPB-CS (C), and
TEPB-CS-g-mPEG (D). Electrophoretic mobility of pDNA with the chitosan derivatives at
N+/P- and P+/P- ratios: Lane 1 (8:1 ratio), Lane 2 (4:1), Lane 3 (2:1), Lane 4 (1:1), Lane 5 (1/2:1),
and Lane 6 (naked pDNA)
3.4. Circular Dichroism (CD)
CD analysis was used to observe electrostatic interaction with calf thymus DNA and
chitosan derivatives. For these studies, the compounds TEAB-CS, TEPB-CS, TEAB-CS-gmPEG, and TEPB-CS-g-mPEg synthesized were studied in great detail. CD spectra for B-form
double-stranded DNA was first measured. Varying amounts of polymer were then added to the
DNA to see how the spectra would change. It’s important to note that chitosan and the
derivatives studied do not produce a signal in the wavelengths studied. In the calf thymus DNA,
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there are positive and negative ellipticities that are centered around 280 nm (positive) and 250
nm (negative). These findings are in accordance with literature values found for B-form
DNA.59,61,62 Figure 15 shows the CD spectra of calf DNA along with the different derivatives
studied. For this figure, the concentration of the polymer is 4x the amount of DNA. In previous
work, it was discovered that these compounds fully complex at these concentrations. As can be
seen in Figure 15, the compound that changes the conformation of B-DNA is TEAB-CS. It is
also worth noting that the mPEG versions of each derivative don’t seem to have the same effect
as their un-peglyated versions. The compound that has the least effect on the conformation of
the DNA is TEPB-CS, indicating that it would perhaps be the best candidate for further studies
with cytotoxicity. As the weight ratios of each compound are increased the conformational
change to DNA is drastic. This indicates that the compounds are interacting with DNA but are
also denaturing it. CD analysis indicates that the compounds are interacting with DNA at
concentrations that agree with Wyatt’s previous results. For every compound, even at just
weight ratios of 2:1 polymer to DNA, there is a slight change in the CD spectra indicating that
conformational changes are occurring. The largest difference comes around weight ratios 4 and
8 where the positive and negative ellipticities are almost completely flattened.

34

275

280

285

290

295

300

305

310

315

320

Wavelength (nm)

35
200

205

210

215

220

225

230

235

240

245

250

255

260

265

20

270

(θ) (deg cm^2/dmol)

200

205

210

215

220

225

230

235

240

245

250

255

260

265

270

275

280

285

290

295

300

305

310

315

320

(θ) (deg cm^2/dmol)

TEAB-CS

20

15

10

5
Calf DNA

0
2x

-5
4x

8x

-10
16x

-15

-20

Wavelength (nm)

TEAB-CS-g-mPEG

15

10

5
Calf DNA

0
2x

4x

-5
8x

-10
16x

-15
32x

-20

TEPB-CS

25

(ϴ) (deg cm^2/dmol)

20
15
10

Calf DNA

5

2x

0

4x

-5

8x

-10

16x
32x

-15

200

210

220

230

Wavelength (nm)

240

250

260

270

280

290

300

310

320

-20

TEPB-CS-g-mPEG
20

(θ) (deg cm^2/dmol)

15
10
Calf DNA

5

2x

0

4x
-5

8x

-10

16x

-15

32x

320
316
312
308
304
300
296
292
288
284
280
276
272
268
264
260
256
252
248
244
240
236
232
228
224
220
216
212
208
204
200

-20

Wavelength (nm)

Figure 15. CD spectra of Calf Thymus DNA interacting with chitosan derivatives.
3.5. Dynamic Light Scattering (DLS) Size Determination
DLS measurements were taken in order to confirm that the DNA/polymer complex
(polyplex) would be small enough to enter cells and be efficient gene therapy vectors. Cells
usually uptake polyplexes ranging from 50 to several hundred nanometers.63 Polyplexes were
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formed in both water and phosphate buffer saline solution (PBS) at pH 7.4. Increasing amounts
of polymer were added to determine optimal size. Ratios for the experiments were done in
DNA:Polymer weight ratios ranging from 1:1 to 1:10. Experiments were run in triplicate and
averaged to determine size. Standard deviations for each measurement were also calculated.
Table 3 shows the results for the polyplexes in water while Table 4 represents runs in PBS.
TEAB-CS has the smallest polyplexes when compared to the other compounds.
However, increasing the weight ratios of all polymers leads to an increase in hydrodynamic
diameter. This could be due to the hydration of counter ions associated with the polycations
which results in swelling of the nanoparticles. These results are comparable to those found in
literature.63 Polyplexes formed from quarternized cellulose with pDNA at N/P ratios of 1:1 gave
sizes in the range of 1380 and 1070 nm, but increasing the N/P ratios resulted in particle sized in
the range of about 400-500 nm.64 It is also interesting to note that the standard deviations for
measurements in PBS were smaller. This could be due to the controlled pH of the buffer
solution keeping the DNA in a stable state. In the water measurements, distilled, deionized water
was used so slight changes to pH from chitosan compounds could drastically change the pH of
the system. DLS measurements were able to confirm that the polyplexes formed by the chitosan
derivatives and calf DNA are small enough to enter cells.

Table 3. Size of DNA/Polymer Complexes in Water
DNA:Polymer
Weight Ratio
1:1

TEAB-CS

TEAB-CS-g-mPEG

TEPB-CS

TEPB-CS-g-mPEG

141 ± 31

234 ± 21

262 ± 30

250 ± 42

1:2

193 ± 26

268 ± 16

200 ± 30

309 ± 9

1:3

197 ± 33

252 ± 25

282 ± 45

233 ± 23
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Table 4. Size of DNA/Polymer Complexes in PBS at pH 7.4
DNA:Polymer
Weight Ratio
1:1

TEAB-CS

TEAB-CS-g-mPEG

TEPB-CS

TEPB-CS-g-mPEG

190 ± 9

168 ± 4

186 ± 7

206 ± 22

1:2

210 ± 10

186 ± 2

252 ± 14

248 ± 9

1:3

221 ± 13

242 ± 32

245 ± 24

252 ± 9

1:4

254 ± 30

259 ± 4

268 ± 11

256 ± 31

1:5

236 ± 10

322 ± 7

320 ± 24

333 ± 19

1:10

282 ± 8

277 ± 2

304 ± 9

333 ± 12

3.6. Zeta Potential
Zeta potential measurements were taken to determine complete complexation between
chitosan derivatives and calf thymus DNA. Measurements were taken with a Brookhaven
NanoBrook Omni particle analyzer with a scattering angle of 173º. Final concentration of DNA
in the 1.5 mL sample cell was 15 µg/mL. Increasing amounts of polymer were then added to the
DNA in weight ratios from 1:1 to 8:1 (polymer:DNA). Polymers used for this experiment were
TEAB-CS, TEPB-CS, TEPB-CS-g-mPEG, and TEAB-CS-g-mPEG. The results can be seen in
Figure 16. All compounds start around 35 mV to -30 mV. As the ratio moves to 2:1, the
pegylated compounds have a huge jump to around -10 mV to -5 mV while the unpeglyated
compounds stay relatively unchanged at around -30 mV to -25 mV. When the ratio is 3:1, all
compounds have zeta potentials that become positive indicating that the DNA and polymer are at
equal N+/P- or P+/P- charge ratios and have complexed. Once the ratio has gone above 4:1 there
is a plateau of the zeta potential for each zeta potential. The pegylated compounds seem to
plateau at a lower zeta potential which is probably due to the mPEG reducing the charge of the
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quarternary groups attached to chitosan. All compounds studied in this experiment show
complete condensation with DNA at a weight ratio of 3:1. Adding polymer past this ratio results
in positive zeta potentials resulting in complete complexation of DNA with extra polymer that

(

)

does not interact with DNA.

Figure 16. Zeta potentials for DNA/polymer complexes. Measurements were taken in triplicate
and error bars are shown for the standard deviation of each point.
3.7. Solubility Studies
Solubility studies were conducted on TEAB-CS, TEPB-CS, TEAB-CS-g-mPEG, and
TEPB-CS-g-mPEG to determine if the addition of the ammonium and phosphonium groups
aided in making chitosan soluble in neutral aqueous media. Figure 17 shows the results for the
studies. It was found that for each compound, even the PEGylated ones, that they were soluble
in all conditions up to pH 10. Further pH increases were not recorded as physiological pH is 7.4
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and the study went well above that. Chitosan was also tested as a control and found that it
crashes out of solution at around pH 6.
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Figure 17. %T versus pH for chitosan derivatives.

40

8

9

10

11

12

13

CHAPTER 4. CONCLUSION

In this work, ammonium and phosphonium substituted chitosan derivatives were
synthesized with the goal of making chitosan more soluble in neutral pH. The compounds were
also designed to interact with DNA to be efficient vectors for gene therapy uses. The degree of
substitution for each compound was determined using 1H NMR and found that altering the
amount of acid added to chitosan had no effect on the degree of substitution. Most of the
compounds had degree of substitution around 16-30%. 1H NMR was also used to determine if
complete reaction had occurred between chitosan and the carboxylic acid ligand. FT-IR analyses
also aided in determining complete conjugation of the ligands to chitosan. Agarose gel
electrophoresis showed that these novel chitosan derivatives do interact with pDNA at charge
ratios of 4x for both ammonium and phosphonium derivatives. Further work on the compounds
TEABA-CS and TEPBA-CS should be conducted in regard to size and zeta potential
measurements. Cytotoxicity studies should also be conducted.
The compounds synthesized by Wyatt, TEPB-CS and TEAB-CS, as well as the
PEGylated versions of these compounds were studied with agarose gel electrophoresis as well.
It was found that these compounds also interact with DNA at charge ratios of 4x that of DNA.
Solubility studies show that even at pH near 10 that these compounds are soluble. DLS
measurements were conducted to determine polyplex size. It was found that they are in the 200400 nm range and can enter cells easily at this size. Zeta potentials were also conducted for
these derivatives to determine when complete complexation had occurred. All compounds at a
weight ratio of 3x that of DNA showed zeta potentials at zero or positive meaning that
complexation had occurred. CD analysis also determined that at these compounds at weight
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ratios 4x those of DNA started to change the conformation of the DNA. Cytotoxicity studies and
transfection efficiency had been previously studied on these compounds, so the work with
Wyatt’s derivatives is concluded.
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APPENDICES
Appendix A. NMR
1

H NMR spectra were collected using a Varian 400 MHz NMR spectrometer and plotted

using Bruker TopSpin software. All spectra presented in this appendix display a ppm range of 014. Red lines indicate the range of integration and the values found for those integrations are
below the peaks. The ppm values of all signals are indicated above the spectra.

Appendix A-1. 1H NMR spectrum of 4-methyltriethylphosphine benzoic acid.
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Appendix A-2. 1H NMR spectrum of 4-methyltriethylamine benzoic acid.

Appendix A-3. 1H NMR spectrum of 2-(N-4-triethylphosphonium) benzamide chitosan run 3
(TEPBA-CS-3).
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Appendix A-4. 1H NMR spectrum of 2-(N-4-triethylphosphonium) benzamide chitosan run 4
(TEPBA-CS-4).

Appendix A-5. 1H NMR spectrum of 2-(N-4-triethylphosphonium) benzamide chitosan run 5
(TEPBA-CS-5).

50

Appendix A-6. 1H NMR spectrum of 2-(N-4-triethylphosphonium) benzamide chitosan run 6
(TEPBA-CS-6).

Appendix A-7. 1H NMR spectrum of 2-(N-4-triethylphosphonium) benzamide chitosan run 7
(TEPBA-CS-7).
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Appendix A-8. 1H NMR spectrum of 2-(N-4-triethylphosphonium) benzamide chitosan run 8
(TEPBA-CS-8).

Appendix A-9. 1H NMR spectrum of 2-(N-4-triethylphosphonium) benzamide chitosan run 10
(TEPBA-CS-10).
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Appendix A-10. 1H NMR spectrum of 2-(N-4-triethylphosphonium) benzamide chitosan run 11
(TEPBA-CS-11).

Appendix A-11. 1H NMR spectrum of 2-(N-4-triethylammonium) benzamide chitosan run 1
(TEABA-CS-1).
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Appendix A-12. 1H NMR spectrum of 2-(N-4-triethylammonium) benzamide chitosan run 2
(TEABA-CS-2).

Appendix A-13. 1H NMR spectrum of 2-(N-4-triethylammonium) benzamide chitosan run 4
(TEABA-CS-4).
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Appendix A-14. 1H NMR spectrum of 2-(N-4-triethylammonium) benzamide chitosan run 5
(TEABA-CS-5).

Appendix A-15. 1H NMR spectrum of 2-(N-4-triethylammonium) benzamide chitosan run 6
(TEABA-CS-6).
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Appendix A-16. 1H NMR spectrum of 2-(N-4-triethylammonium) benzamide chitosan run 7
(TEABA-CS-7).

Appendix A-17. 1H NMR spectrum of 2-(N-4-triethylammonium) benzamide chitosan run 8
(TEABA-CS-8).
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Appendix B. FT-IR
IR spectra were collected using a Bruker Vertex 70 FT-IR spectrometer and plotted
using Bruker OPUS 7.5 software. The spectra in this appendix display wavenumbers from 4004000 cm-1 to display the amide, C-O, N-H, C-H, C-N+, and C-P+ stretch peaks found on coupled
chitosan derivatives.

Appendix B-1. IR spectrum of 95% DA chitosan.
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Appendix B-2. IR spectrum of 2-(N-4-triethylphosphonium) benzamide chitosan.
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Appendix B-3. IR spectrum of 2-(N-4-triethylammonium) benzamide chitosan.
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